Are Insurers Slighting Sjögren’s Patients?
When you have a disease nobody has heard of, it’s easy to feel alone. And when insurance companies make it harder for you to access treatment, it can become even more disheartening. I know these feelings all too well.
Why Medical Innovation is Slow to Reach Patients
It can take 17 years for medical breakthroughs to move from the lab to the clinic, where patients can finally benefit. Why the lag?
How Telehealth Changed My Mom’s Life
Watching a patient eat. Asking about family photos on the nearby coffee table. Observing the living space. These are all benefits of telemedicine that help doctors see their patients through a new lens.
Will Insurers Come Through for Respiratory Patients?
This could be a life-changing year for chronic respiratory patients.
For Some, Step Therapy Is a Matter of Death or Life
I had been experiencing chest pain for a while. It was robbing me of joy – and it was often embarrassing.
Insurers Block Pain-Blocking Devices for Migraine
For the 39 million Americans who experience migraine headaches, noninvasive devices offer a new option for stopping painful symptoms. Insurers, however, are giving the devices the cold shoulder.
Insurers Save Costs at Cost of Skin Patients
Everyone, it seemed, was willing to help patients access medication without delay when COVID-19 took hold last year.
When Prescribing is Personal
Prescribing became more personalized during the pandemic, a new survey of health care providers suggests.
Will the Biden Administration Tackle Co-Pay Card Reform?
The Biden administration’s ambitious plan to protect patients is off to a promising start.
Treating Heart Disease and Type 2 Diabetes in Silos Isn’t Working
Heart disease and Type 2 diabetes aren’t just common. They commonly occur together. So why does the health care system force patients with both conditions to treat one disease at a time?
